Altimmune (ALT) Leases (2019 - 2024)
Historic Leases for Altimmune (ALT) over the last 6 years, with Q4 2024 value amounting to $1.6 million.
- Altimmune's Leases rose 35151.52% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year increase of 35151.52%. This contributed to the annual value of $1.6 million for FY2024, which is 35151.52% up from last year.
- As of Q4 2024, Altimmune's Leases stood at $1.6 million, which was up 35151.52% from $1.7 million recorded in Q3 2024.
- In the past 5 years, Altimmune's Leases ranged from a high of $1.7 million in Q2 2024 and a low of $300000.0 during Q1 2024
- For the 5-year period, Altimmune's Leases averaged around $815270.6, with its median value being $725500.0 (2022).
- Examining YoY changes over the last 5 years, Altimmune's Leases showed a top increase of 35151.52% in 2024 and a maximum decrease of 4454.71% in 2024.
- Over the past 5 years, Altimmune's Leases (Quarter) stood at $903825.0 in 2020, then decreased by 11.71% to $798000.0 in 2021, then dropped by 25.31% to $596000.0 in 2022, then plummeted by 39.09% to $363000.0 in 2023, then skyrocketed by 351.52% to $1.6 million in 2024.
- Its last three reported values are $1.6 million in Q4 2024, $1.7 million for Q3 2024, and $1.7 million during Q2 2024.